CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $47,096,000 | +17.1% | 2,169,351 | -18.4% | 0.20% | +5.7% |
| Q4 2020 | $40,212,000 | +48.8% | 2,657,796 | +25.1% | 0.19% | +38.1% |
| Q3 2020 | $27,033,000 | -17.3% | 2,124,421 | +11.2% | 0.14% | -26.5% |
| Q2 2020 | $32,675,000 | +71.5% | 1,910,821 | +32.5% | 0.19% | +53.7% |
| Q1 2020 | $19,054,000 | -18.0% | 1,442,421 | 0.0% | 0.12% | +5.1% |
| Q4 2019 | $23,237,000 | -31.9% | 1,442,421 | -22.7% | 0.12% | -37.8% |
| Q3 2019 | $34,113,000 | -18.1% | 1,866,188 | -3.7% | 0.19% | -18.6% |
| Q2 2019 | $41,671,000 | +116.5% | 1,938,188 | +97.5% | 0.23% | +108.1% |
| Q1 2019 | $19,251,000 | +77.0% | 981,220 | +17.3% | 0.11% | +63.2% |
| Q4 2018 | $10,876,000 | -18.5% | 836,642 | +50.2% | 0.07% | -4.2% |
| Q3 2018 | $13,340,000 | +25.1% | 557,000 | 0.0% | 0.07% | +16.4% |
| Q2 2018 | $10,666,000 | +373.2% | 557,000 | +205.9% | 0.06% | +369.2% |
| Q1 2018 | $2,254,000 | +80.6% | 182,100 | +78.5% | 0.01% | +85.7% |
| Q4 2017 | $1,248,000 | – | 102,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |